Semaglutide
STEP UP
Novo Nordisk · Phase 3 · Completed · Enrollment 1407
Y axis: Change in body weight from baseline, %
X axis: Weeks since randomization
Cited trial source. Only weeks the source states.
- Semaglutide 7.2 mg: week 72 -18.8%
- Semaglutide 2.4 mg: week 72 -15.5%
- Placebo: week 72 -3.9%
One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.